Navigation Links
Neogen Names Quinlan as CFO
Date:1/6/2011

LANSING, Mich., Jan. 6, 2011 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced today that it has named Steven J. Quinlan as the Company's chief financial officer to replace the retiring Richard Current. Current will immediately relinquish his responsibilities as CFO, but will remain with Neogen through the end of the fiscal year, May 31.

Quinlan joins Neogen following 19 years at Detrex Corporation, the last eight as CFO, vice president of finance, and treasurer. In the position, he was responsible for all of Detrex's finance, accounting, and reporting activities. Detrex is a publicly held diversified manufacturer of PVC and CPVC pipe, duct and shapes, and specialty chemicals including additives for industrial petroleum products and high purity hydrochloric acid.

"While we understand the challenge of trying to replace Rick's extensive skills and experience, we are very pleased to have found someone of Mr. Quinlan's caliber to fill the position," said Lon Bohannon, Neogen's president. "His many years as a CFO, combined with his experience as a CPA and knowledge of SEC procedures and regulations, will serve Neogen well as we go forward."

After graduating from the University of Michigan with a degree in business administration, Quinlan earned his CPA while working as an auditor at Price Waterhouse for more than four years; he also served in various financial positions for Ford Motor Company. He joined Detrex as a division controller after completing his MBA at Wayne State University in 1991.  

Current assumed the position of Neogen's CFO in November 1999, and has helped drive the company's consistent earnings growth and heightened stature in the investment community. He will remain an employee of Neogen through the end of the current fiscal year to ensure an orderly transition for the role of CFO.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.


'/>"/>
SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Reports 33% Increase in Net Income
2. Neogen Corporation Announces 2nd Quarter Results Conference Call
3. Neogens Rapid Test for Salmonella enteritidis Receives AOAC Approval
4. NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010
5. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
6. Neogen Corporation Announces 3rd Quarter Results Conference Call
7. Neogen Reports 18% Increase in Net Income
8. Richard T. Crowder Joins Neogens Board of Directors
9. Neogen Announces 3 for-2 Stock Split
10. Neogen to Ring NASDAQs Closing Bell
11. NeoGenomics To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 18, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:6/9/2016)... ISTANBUL , June 9, 2016  Perkotek an innovation leader in attendance control ... to seamlessly log work hours, for employers to make sure the right employees are ... Logo - http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
Breaking Biology News(10 mins):